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Introduction
Confounding and effect modification, two very important 
statistical concepts that may occur both in the statistical 
modelling of epidemiological data and other medically related 
data are seldom considered during the analysis of data. This 
is rather unfortunate as this may introduce some degree of 
bias in the statistical interpretation following the analysis.
Confounding and effect modification arc a major cause for 
concern in medicine. Epidemiology is an example of that 
branch of medicine where confounding and effect modification 
arc commonly applied.
Confounding.
Confounding in the estimation of the effect of a given factor 
(in producing disease) is the distortion in the estimate 
attributable to an extraneous variate.1-2 A confounder is 
defined as a variable which, if not controlled, produces a 
distortion in the estimated effect of a study exposure in the 
absence of misclassification.3 For a variable to be a confounder, 
it must be a determinant of the disease and not intermediate 
in the causal pathway from exposure of interest to disease.4 A 
covariate can be said to confound if the measure of an 
association between an exposure and a disease differs 
according to whether or not the estimate is adjusted for the 
disease.5
Confounding can be divided into two broad categories: the 
‘comparability based’ and the ‘collapsibi 1 ily based’.6
The ‘comparability based’ is defined as the bias in the 
estimation of the effects of an exposure on a disease risk due 
to inherent differences between exposed and unexposed 
individuals. A practical way by which this can occur is in a 
clinical trial where two treatments (say Treatment A and 
Treatment B) are to be assigned to a group of patients or vice 
versa. In order to reduce confounding in this case, patients 
assigned to both treatments should be comparable. The 
‘comparability based’ confounding occurs as a result of
differences between certain stratified (conditional) statistical 
measures of association and the corresponding crude 
(unconditional or collapsed) measure. Most definitions of 
confounding fall into these categories.
From a ‘collapsibility based’ point of view, confounding is 
the failure of a crude parameter to equal the value of the 
parameter that would have been obtained upon control of 
confounders.7 A ‘collapsibility based’ approach entails that 
the confounder should be specified and control of the 
confounder should be defined before the problem of 
confounding can be tackled. Confounding in the study design 
can be explained by thccovariatc’s relationship to the way the 
population was sampled and/or from errors of observation 
associated with the covariatc.8 
Positive and Negative Confounding.
Brcslow and Day1 define the concept of positive and negative 
confounding. Positive confounding is defined as a situation 
whereby ignoring the confounder will make the association 
between the exposure and the disease risk more positive than 
it should be. Negative confounding on the other hand is 
defined as that situation where on ignoring the confounder 
will make die association between an exposure and a disease 
less positive than it should be.
Control of Confounding.
There arc two possible errors that can arise from confounding:1 
dicse arc when no attempt is made to control for the confounder 
and when a non confounder is controlled for.
Misclassification of a confounder leads to loss of ability to 
control for confounding, although control may still be useful 
provided that the misclassification of the confounder is non- 
differential.1'
Misclassification of exposure may bring about a greater 
problem if factors which influence misclassification occur as 
confounders, and control for these factors may increase net 
bias.
It is, therefore, apparent that confounding may be controlled 
for in the design or at the analysis stage or at both stages.3
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There are three major methods of controlling for 
confounding at the design stage.2 The first method is 
randomization, which is usually practised in potential cohort 
designs. Secondly is restriction of the studies to narrow 
ranges of values for the potential confounders.3 The third 
method of controlling for confounding is matching on potential 
confounding factors. Matching is carried out in both case 
control and cohort studies. Matching as claimed does not 
reduce confounding, but controls for it in the analysis. 
Matching also usually increases the precision of effect 
estimates.
In certain cases it is not possible to control for confounding 
in the study design. The best estimate of an association is 
obtained when the true confounding covariates are known 
and have been adjusted for in the analysis.5 At the analysis 
stage, control for confounding involves stratifying the data 
according to the levels of the confounder(s) and calculating 
the effect estimate that summarizes the information across 
the strata of the confounder(s).
The major disadvantage in stratification is that it is seldom 
possible to control for more than two or three confounders in 
the analysis.3 There is no guarantee that there will ever be a 
point in stratification at which the stratum-specific parameters 
will change when one stratifies on a different risk factor.7 
Statistical modelling is thus recommended as a means for the 
simultaneous control of more confounders.3
The problems of confounding are due to the fact that most 
authors have not taken into account the fact that there exist 
two separate and distinct phenomena that can give rise to 
confounding.'°Thesephenomena, are the ‘non-collapsibility’ 
and the ‘non-comparability’(inadequacy of the control) of 
the disease exposure association. Since confounding due to 
the inadequacy of the control group is primarily due to the 
observational nature of epidemiologic studies, eliminating 
confounding due to this source should be the main focus of 
the design phase of the study. ‘Non-collapsibility’, being a 
property of the target population should be identified and 
controlled for in the analysis. This is because non-collapsibility 
isafunction of the target population and cannot be clim inated. 
Effect Modification.
Effect modification is an interaction between a confoundcr 
and an exposure of interest." This signifies that effect 
modification can be considered to be a special case of 
confounding. Effect modification can also be looked upon as 
the joint effects o f two or more factors that occur when the 
study factor depends on the level of another factor in the study 
base.12 In epidemiology, effect modification is of equally 
significant importance as confounding. Effect modification 
and confounding are related, but different concepts. This is 
perhaps elucidated in the above definition of effect 
modification.
Discussion
The ideas and principles underlying confounding and effect 
modification have been elaborately discussed. This paper 
should enable many inexperienced medical researchers and 
epidemiologists to understand in more detail the concepts of 
confounding and effect modification.
Many studies have been carried out where the possibility of 
confounding (or effect modification) was not taken into 
account. The outcome of these studies could have been
seriously misleading.
Great care should be taken at the design and analysis stages 
of the study. It is thus recommended that medical researchers 
should ensure that the effect of confounding and effect 
modification is minimized. This is accomplished by identifying 
every potential confounding variable (this is not very 
plausible), and also methods by which these variables can be 
controlled for in the analysis, at the design stage or at both 
stages.
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